DR.NOAH BIOTECH's AI-driven ALS Medicine Receives U.S. FDA Approval for Phase 1 Clinical Trial IND SEOUL, KOREA, Sept. 02, 2024 (GLOBE NEWSWIRE) -- DR.NOAH BIOTECH (hereafter DR.NOAH), an AI-driven innovative drug development company, announced on August 23 that it had received approval from the...